The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations

被引:45
作者
Aung, Lynn Htet Htet [1 ]
Yin, Rui-Xing [1 ]
Miao, Lin [1 ]
Hu, Xi-Jiang [1 ]
Yan, Ting-Ting [1 ]
Cao, Xiao-Li [1 ]
Wu, Dong-Feng [1 ]
Li, Qing [1 ]
Pan, Shang-Ling [2 ]
Wu, Jin-Zhen [1 ]
机构
[1] Guangxi Med Univ, Dept Cardiol, Inst Cardiovasc Dis, Affiliated Hosp 1, Nanning 530021, Guangxi, Peoples R China
[2] Guangxi Med Univ, Dept Pathophysiol, Sch Premed Sci, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
DENSITY-LIPOPROTEIN CHOLESTEROL; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; CORONARY-ARTERY-DISEASE; RISK-FACTOR; PCSK9; GENE; SEQUENCE VARIATIONS; APOLIPOPROTEIN-B; PLASMA-LEVELS; RECEPTOR; METABOLISM;
D O I
10.1186/1476-511X-10-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Background: Proprotein convertase subtilisin-like kexin type 9 (PCSK9) plays a key role in regulating plasma low-density lipoprotein cholesterol (LDL-C) levels. However, the association of E670G (rs505151) polymorphism in the PCSK9 gene and serum lipid levels is inconsistent in several previous studies. The present study was undertaken to detect the association of PCSK9 E670G polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Methods: A total of 649 subjects of Bai Ku Yao and 646 participants of Han were randomly selected from our previous samples. Genotypes of the PCSK9 E670G polymorphism were determined via polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by direct sequencing. Results: Serum levels of total cholesterol, high-density lipoprotein cholesterol (HDL-C), LDL-C, and apolipoprotein (Apo) AI were lower in Bai Ku Yao than in Han (P < 0.01 for all). The frequency of G allele was 2.00% in Bai Ku Yao and 4.80% in Han (P < 0.01). There was significant difference in the genotypic and allelic frequencies between Bai Ku Yao and Han (P < 0.01); between normal LDL-C (<= 3.20 mmol/L) and high LDL-C subgroups (> 3.20 mmol/L, P < 0.01) in Bai Ku Yao; and between normal HDL-C (>= 0.91 mmol/L) and low HDL-C (< 0.91 mmol/L, P < 0.05), between normal ApoAI (>= 1.00 g/L) and low ApoAI (< 1.00 g/L, P < 0.05), or between normal ApoAI/ApoB ratio (>= 1.00) and low ApoAI/ApoB ratio (< 1.00, P < 0.01) subgroups in Han. The G allele carriers in Han had higher serum HDL-C levels and the ratio of ApoAI to ApoB than the G allele noncarriers. The G allele carriers in Han had higher serum HDL-C and ApoAI levels than the G allele noncarriers in males (P < 0.05 for each), whereas the G allele carriers had lower serum ApoB levels and higher the ratio of ApoAI to ApoB than the G allele noncarriers in females (P < 0.05 for all). Serum HDL-C and ApoAI levels in Han were correlated with genotypes (P < 0.05) in males, and serum ApoB levels and the ratio of ApoAI to ApoB were associated with genotypes (P < 0.05) in females. Conclusions: The PCSK9 E670G polymorphism is mainly associated with some serum lipid parameters in the Han population. The G allele carriers had higher serum HDL-C and ApoAI levels in males, and lower serum ApoB levels and higher the ApoAI/ApoB ratio in females than the G allele noncarriers.
引用
收藏
页数:15
相关论文
共 66 条
[1]
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia [J].
Abifadel, M ;
Varret, M ;
Rabès, JP ;
Allard, D ;
Ouguerram, K ;
Devillers, M ;
Cruaud, C ;
Benjannet, S ;
Wickham, L ;
Erlich, D ;
Derré, A ;
Villéger, L ;
Farnier, M ;
Beucler, I ;
Bruckert, E ;
Chambaz, J ;
Chanu, B ;
Lecerf, JM ;
Luc, G ;
Moulin, P ;
Weissenbach, J ;
Prat, A ;
Krempf, M ;
Junien, C ;
Seidah, NG ;
Boileau, C .
NATURE GENETICS, 2003, 34 (02) :154-156
[2]
Hypolipidemic effect of Telfairia occidentalis (Fluted pumpkin) in rats fed a cholesterol-rich diet [J].
Adaramoye, O. A. ;
Achem, J. ;
Akintayo, O. O. ;
Fafunso, M. A. .
JOURNAL OF MEDICINAL FOOD, 2007, 10 (02) :330-336
[3]
METAANALYSIS OF THE EFFECTS OF SOY PROTEIN-INTAKE ON SERUM-LIPIDS [J].
ANDERSON, JW ;
JOHNSTONE, BM ;
COOKNEWELL, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :276-282
[4]
[Anonymous], 2002, ZHONGHUA LIU XING BI, V23, P5, DOI DOI 10.3760/J.ISSN:0254-6450.2002.01.003
[5]
NARC-1/PCSK9 and its natural mutants -: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol [J].
Benjannet, S ;
Rhainds, D ;
Essalmani, R ;
Mayne, J ;
Wickham, L ;
Jin, WJ ;
Asselin, MC ;
Hamelin, J ;
Varret, M ;
Allard, D ;
Trillard, M ;
Abifadel, M ;
Tebon, A ;
Attie, AD ;
Rader, DJ ;
Boileau, C ;
Brissette, L ;
Chrétien, M ;
Prat, A ;
Seidah, NG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (47) :48865-48875
[6]
Boden WE, 2000, AM J CARDIOL, V86, p19L
[7]
CEN L, 1984, J GUANGXI MED U, V1, P20
[8]
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis [J].
Chen, SN ;
Ballantyne, CM ;
Gotto, AM ;
Tan, YL ;
Willerson, JT ;
Marian, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1611-1619
[9]
Low LDL cholesterol in African Americans resulting from frequent nonsense mutations in PCSK9 [J].
Cohen, J ;
Pertsemlidis, A ;
Kotowski, IK ;
Graham, R ;
Garcia, CK ;
Hobbs, HH .
NATURE GENETICS, 2005, 37 (03) :328-328
[10]
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease [J].
Cohen, JC ;
Boerwinkle, E ;
Mosley, TH ;
Hobbs, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (12) :1264-1272